SAMIR N. PARIKH, M.D.

Plain English
This study focused on analyzing a specific impurity found in molnupiravir capsules, an antiviral medication used to treat COVID-19. Researchers developed a robust testing method that confirmed the presence of an impurity called N-hydroxycytidine and found it could potentially cause liver damage, mitochondrial issues, and reproductive toxicity. These findings are important because they highlight the need for further safety tests to ensure the drug is safe for patients, thereby ensuring quality control for its use. Who this helps: This helps patients relying on molnupiravir for COVID-19 treatment.

Plain English
This study looked at surgical methods for treating fractures in the wrist, specifically those involving a small but critical piece of bone called the volar lunate facet, which impacts wrist stability. The authors found that using specific surgical techniques can successfully fix these fractures, improving patient outcomes, and noted that proper planning and imaging during the surgery is crucial for success. This matters because better surgical techniques can lead to fewer complications and help patients regain wrist function more effectively. Who this helps: Patients with distal radius fractures.

Plain English
This study looked at how umbilical cord blood transplants (UCBT) can help patients with chronic granulomatous disease (CGD) who do not have matching donors. Researchers analyzed 39 male patients and found that while nearly one-quarter (23.1%) experienced early graft failure, most patients who survived showed significant improvement in health, with a 3-year survival rate of 73.7%. This research is important as it highlights UCBT as a viable option for CGD patients in need, particularly when suitable donors are unavailable. Who this helps: This helps patients with CGD who lack HLA-matched donors.

Plain English
This research studied how certain fats, called ceramides, contribute to kidney injury during acute kidney injury (AKI). The researchers found that high levels of these harmful ceramides in kidney cells were linked to more severe kidney damage, with urine tests predicting the severity of injury in both adults and children. By blocking the production of ceramides in mice, they were able to protect the kidneys from damage and saw this approach as a promising new way to treat kidney injuries. Who this helps: This helps patients at risk for kidney damage, including those with conditions that can lead to acute kidney injury.

Plain English
Researchers studied the long-term outcomes of 308 patients with Wiskott-Aldrich syndrome (WAS) who received a stem cell transplant between 1990 and 2018. They found that 87.2% of patients survived for five years after the procedure, and 79.7% remained free of serious health issues. Key factors affecting survival included the patient's age (those older than 5 had poorer outcomes), donor match type, and prior severe infections, emphasizing the importance of performing transplants early before serious complications arise. Who this helps: This benefits patients with Wiskott-Aldrich syndrome and their families.

Plain English
This study looked at 193 women who are carriers of Wiskott-Aldrich syndrome (WAS), a rare genetic disorder. It found that 13% had low platelet counts, 22% had eczema, 33% reported frequent infections, and 24% experienced autoimmune disorders. Additionally, many reported feelings of guilt (91%), anxiety (41%), and depression (44%). Understanding these issues can help in developing better healthcare and support for these carriers. Who this helps: This benefits women who are carriers of Wiskott-Aldrich syndrome and their families.

Plain English
This study looked at the long-term safety and effectiveness of a new type of blood vessel, called Symvess, used to repair arteries in injured limbs when the patient's own veins can't be used. Researchers followed 54 patients for up to 36 months and found that 58.3% of blood vessel repairs continued to work well after one year, with 87.3% of limbs saved from amputation. Notably, infections were very low, with a 92.9% rate of patients remaining infection-free after three months. Who this helps: This benefits patients with severe limb injuries who do not have suitable veins for surgery.

Plain English
This study looked at how specific cells in the eye, called ipRGCs, change in mice with Alzheimer's disease (AD) as they age. Researchers found that these cells begin to show signs of damage as early as 4-8 months old, while other related cells start to degenerate by 12-16 months. This matters because it indicates that problems with these eye cells can happen before people start showing memory issues, which could help doctors spot Alzheimer's earlier. Who this helps: Patients at risk for Alzheimer's disease.

Plain English
This research looks at ways to lower fat levels in the blood to prevent a serious issue called cardiac allograft vasculopathy (CAV) that can occur after heart transplants. The study found that using statins, a type of cholesterol-lowering medication, has been effective in reducing the rates of CAV and improving survival after transplant, but there’s still uncertainty about how other types of medications for lowering cholesterol might help. This matters because finding effective treatments for CAV can improve long-term heart transplant outcomes and patient health. Who this helps: This helps patients who have received heart transplants.

Plain English
This study looked at the effects of starting enzyme replacement therapy (ERT) early in life for patients with infantile-onset Pompe disease (IOPD). Researchers found that of 17 patients treated within four weeks of birth, 16 are alive and active years later, and most have shown improvements in heart and muscle function. Early treatment helps improve the quality of life, but there remains a risk of developing high antibody levels that can complicate care. Who this helps: This research benefits infants diagnosed with Pompe disease and their families.

Plain English
This study looked at Twinkle-related disorders, which are genetic conditions affecting mitochondrial function, in 189 patients from various countries. Researchers found that 85.2% of patients experienced primary mitochondrial myopathy, with common symptoms including muscle weakness (84.7%) and hearing loss (17.5%). This research is important because it helps identify specific genetic patterns and symptoms, which can improve future treatments and clinical trials for these rare disorders. Who this helps: Patients with Twinkle-related disorders and their healthcare providers.

Plain English
This study looked at how setting clear deadlines and providing feedback affected the timely start of surgeries in a busy operating room. After implementing these strategies, the percentage of surgeries that started on time jumped from 39% to 74%, and the monthly average improved from 54.8% to 83.2%. This is important because on-time surgeries lead to better hospital efficiency and can help lower costs. Who this helps: This helps patients and hospital staff by ensuring surgeries start as scheduled.

Plain English
This study tested new automated test kits for quickly analyzing a wide range of drugs, including opioids and stimulants, to help public health laboratories track drug trends and overdose cases. The researchers found that these kits produced highly accurate and reliable results, allowing for faster detection of drug use patterns. This is important because it helps health officials respond more effectively to the growing problem of new psychoactive substances and overdose incidents. Who this helps: This helps public health officials and laboratories monitor drug trends more efficiently and effectively.

Plain English
This study looked at how Body Mass Index (BMI) affects outcomes for patients undergoing major laparoscopic surgery for non-cancerous gynecological issues. Researchers found that out of 883 patients, 55% were obese, and those with higher BMI faced more bleeding, longer surgery times, and hospital stays; however, the overall rates of complications after surgery were similar across different BMI groups once other factors were considered. This matters because it helps doctors understand how a patient's weight can influence surgery outcomes and aids in better planning and expectations for surgical care. Who this helps: This helps patients and doctors by providing insights into surgical risks related to body weight.

Plain English
This study looked at how age affects the outcomes of two different treatments—open surgical bypass using a specific vein (SSGSV) and endovascular therapy (ET)—for patients with severe circulation problems in their limbs. The researchers analyzed data from 1,780 patients and found that patients under the age of 57 had a lower risk of amputation with SSGSV compared to ET, and this advantage continued up to age 83 for major adverse limb events. However, after age 72, the differences in outcomes between the two treatments were minimal. Who this helps: This research benefits patients with chronic limb-threatening ischemia, especially when considering their treatment options based on age.

Plain English
The study explored how exposure to ultraviolet (UV) light affects cancer growth in the lungs, specifically after melanoma spreads there. Researchers found that mice exposed to UV light after their melanoma had better survival rates and slower cancer growth. In people, higher sun exposure was linked to improved survival rates for lung cancer patients. This research suggests that UV light might help boost the immune response against cancer. Who this helps: This helps lung cancer patients and their doctors.

Plain English
This study looked at how documenting energy goals for nutrition impacts the care of critically ill children in the pediatric intensive care unit (PICU). Researchers found that after making an effort to improve documentation, the rate went from 30% to 97%, and early enteral nutrition (EEN) within the first 48 hours increased significantly, leading to shorter hospital stays—4.05 days compared to 3.64 days in the ICU, and 8.25 days versus 6.99 days overall. These results are important because better nutritional planning helps kids recover faster. Who this helps: This helps patients, particularly critically ill children, by improving their nutrition and reducing hospital stays.

Plain English
This study looked at how blood transfusions are used during gene therapy for sickle cell disease (SCD) at one medical center. It found that patients received a median of 38 units of red blood cells throughout the treatment process, with the highest use (20 units) occurring between the first cell collection and the infusion of the new cells. This information is important because it helps doctors plan better for blood needs in SCD patients, especially those with complications from previous transfusions. Who this helps: This research helps doctors and patients with sickle cell disease.

Plain English
Researchers studied the effects of ivermectin on two types of mosquitoes, Anopheles coluzzii and Aedes aegypti, which transmit diseases like malaria and dengue fever. They found that ivermectin significantly increased the death rate of An. coluzzii, with a 64-fold higher risk of death at the highest concentration, and also reduced the number of eggs they laid. However, it had no harmful effects on Aedes aegypti mosquitoes. This research is important because it shows how ivermectin could be used to help control malaria-carrying mosquitoes effectively. Who this helps: This helps public health officials and researchers develop better strategies to fight mosquito-borne diseases.

Plain English
This study looked at how particles called melanosomes released by melanoma cells affect the growth of tumors and the immune response. Researchers found that antibodies targeting a specific protein, HSP70, stopped melanoma cells from growing and helped mice survive longer when given these antibodies before tumors developed. In patients with advanced melanoma who received immune treatments, those with higher levels of anti-HSP70 antibodies had better responses, including complete remission of the disease. Who this helps: Patients with melanoma.

Plain English
This study looked at how effective a quick testing method for heart attacks is in different types of emergency departments: regular hospital ones and freestanding ones. Researchers found that while patients in hospital-based emergency departments had a safe discharge rate of 50.3% with the new testing method, those in freestanding emergency departments had a much higher safe discharge rate of 95% when using the same method. This matters because it shows that faster testing can significantly improve patient outcomes in certain emergency settings, allowing more people to safely go home sooner. Who this helps: Patients visiting freestanding emergency departments.

Plain English
This study investigated how melanoma cells avoid being attacked by the immune system. Researchers found that melanoma cells release tiny particles called melanosomes that are covered in proteins, which distract and weaken immune cells known as CD8 T cells. By analyzing samples from melanoma patients, they confirmed that these melanosomes trap immune cells, reducing their ability to fight the cancer. Who this helps: This benefits patients with melanoma by identifying a new target for treatments that could improve their immune response against tumors.

Plain English
This study looked at 106 patients who received the Evoque heart valve replacement and found that 25% of those without a prior pacemaker developed new heart conduction issues called atrioventricular (AV) block after the procedure. Most of these cases happened within 26 hours, but some appeared as late as 7 days post-surgery. The good news is that 12 out of 14 patients with new AV block were successfully treated with a small device called a leadless pacemaker, allowing them to recover without complications. Who this helps: This information benefits patients undergoing tricuspid valve replacement, as well as their doctors managing their care.

Plain English
This study looked at older patients, specifically those 80 and older, who were hospitalized due to heart issues related to a heart attack. Between 2003 and 2021, hospitalizations for this group rose from 39,220 to 51,640, but their chances of dying in the hospital decreased from 61.4% to 49%. This matters because it shows that even though more older patients are being treated for serious heart conditions, improvements in care have led to better survival rates. Who this helps: This helps older patients and their families by showing that treatments are improving.

Plain English
The research focused on creating updated guidelines for diagnosing Cyclic Vomiting Syndrome (CVS) in children, a condition that shares symptoms with migraines and another related illness called Cannabinoid Hyperemesis Syndrome (CHS). The expert panel recommended screening tests, such as blood and urine tests and imaging, for all children suspected of having CVS, as they found that many other tests are not cost-effective or helpful. This matters because having clear, evidence-based guidelines can lead to quicker and more accurate diagnoses for children suffering from these debilitating vomiting episodes. Who this helps: Patients, especially children with vomiting issues, and their doctors.

Plain English
This study examined the risk factors that affect the chances of death in COVID-19 patients admitted to a hospital, analyzing data from 399 patients. Researchers found that the overall death rate was 7.8%, and they created a simple scoring system that can help predict who is at higher risk of dying based on factors like age, kidney function, heart and lung health, diabetes, and white blood cell count. This matters because it allows healthcare providers to identify patients who may need more intensive care, especially in areas with limited medical resources. Who this helps: Patients and doctors.

Plain English
This study looked at how cardiac medications were managed for patients with serious heart conditions at the end of their lives. Researchers found that over half (53.4%) of the patients stopped taking these medications before or upon entering a care unit, and those who discontinued their medications experienced significantly more severe pain and required higher doses of opioids compared to those who continued their medications. This is important because it suggests that stopping cardiac medications may lead to worse pain management, especially for heart failure patients, indicating a need for better guidelines for medication use at this stage of care. Who this helps: This helps patients nearing the end of life, their families, and healthcare providers.

Plain English
This study looked at how well patients with kidney cancer treated with a drug called HIF-2α antagonists do when they need surgery afterward. Researchers found that 27 patients had surgical procedures after taking these drugs, with tumors growing at rates of 0.37 cm per year before treatment, 0.46 cm during treatment, and 0.54 cm after treatment; however, the differences in growth rates were not significant. The findings indicate that surgery after this treatment is safe and can be done without major issues, which is important for planning patient care. Who this helps: This helps patients with VHL-related kidney cancer who are considering or needing surgery.

Plain English
This study looked at a 31-year-old man who had a heart issue called a fistula between two parts of his heart. Researchers used 3D printing to create a model of the patient's heart, which helped them successfully close the fistula using a special device. This approach led to a successful repair and shows that using 3D models can improve planning for similar complicated heart problems. Who this helps: This helps patients with complex heart conditions who need surgical repairs.

Plain English
This study looked at how long-term exposure to low levels of ultraviolet B (UVB) radiation affects male and female mice. They found that UVB exposure increased food-seeking behavior in male mice due to a rise in a hormone called ghrelin, but females did not show this increase because of the effects of estrogen. Understanding these differences is important because it highlights how UVB radiation can have different effects on males and females, which can inform treatments for various health conditions. Who this helps: This helps researchers and healthcare providers understand the implications of UVB exposure on metabolic and reproductive health.

Plain English
This study examines two different ways of using measurement-based care (MBC) to treat depression: the standard method that uses paper assessments and an enhanced version (eMBC) that incorporates a mobile app through WeChat for tracking progress and self-management. The researchers are focusing on how effective these methods are for patients: they want to see if the patients using the WeChat app will have better outcomes after six months. They plan to include 1,200 patients and 240 doctors in the research across 12 mental health centers in Shanghai. Who this helps: This benefits patients with depression by potentially improving their treatment outcomes through better tracking and support.

Plain English
This study looked at a new type of engineered artery called the acellular tissue-engineered vessel (ATEV) to treat serious blood vessel injuries in soldiers during combat in Ukraine. Out of 17 patients treated with ATEVs, 87.1% had functioning arteries after 18 months, and there were no infections or amputations among those treated. This matters because it offers a promising new option that can be used in emergency situations when traditional treatments are not available. Who this helps: This benefits injured military personnel and healthcare providers treating combat-related injuries.

Plain English
This study looks at how artificial intelligence (AI) is changing the field of gastroenterology, which focuses on the digestive system and related organs. Researchers found that AI can speed up drug discovery and improve treatment personalization for conditions like inflammatory bowel disease, supporting better patient outcomes. However, they also highlighted challenges like data privacy concerns and the need for consistent data practices to ensure AI is used safely and effectively in healthcare. Who this helps: This benefits patients with digestive disorders and healthcare providers looking for better treatment options.

Plain English
This study focused on a new method to determine the age of mosquitoes, specifically Anopheles gambiae, by analyzing images of their wings. The researchers found that the method accurately reflected mosquito populations caught during a clinical trial, showing that most mosquitoes were younger, with a few older ones. They also discovered that using insecticide-treated bed nets had a significant impact on the age distribution of these mosquitoes, which matters because it helps evaluate how effective mosquito control methods are in reducing diseases transmitted by these insects. Who this helps: Patients in malaria-endemic areas benefit from improved mosquito control strategies.

Plain English
This study tested a new treatment method for melanoma, a type of skin cancer, using a special agent that targets two specific proteins linked to tumor growth. In mouse models, this treatment reduced the size of tumors by 70% and decreased the number of melanoma cells in the bloodstream, which helps prevent the cancer from spreading to other organs. This approach not only shrinks tumors but also boosts the immune system’s ability to fight cancer, making existing treatments more effective. Who this helps: This helps melanoma patients and doctors looking for better treatment options.

Plain English
This research developed and tested a new method to measure two diabetes medications, metformin and vildagliptin, in human blood using advanced lab techniques. The method showed high accuracy with recovery rates of about 89% for metformin and 92% for vildagliptin, and it can effectively measure drug levels within a specific range. This is important because it helps ensure that these medications are being administered correctly in clinical settings. Who this helps: This helps doctors and researchers by providing reliable ways to monitor medication levels in patients.

Plain English
This study looked at a new type of bioengineered blood vessel, called ATEV, to help patients who faced complications after vascular surgeries, particularly when their own veins were not available for repair. In a trial with 12 patients, all but one retained blood flow in the implanted vessels over an average of 23 months, and there were no infections reported in any of the patients. This matters because it shows that ATEV could be a reliable option for saving limbs and maintaining blood flow in situations where traditional repairs are not possible. Who this helps: This helps patients who suffer from vascular complications during or after surgery.

Plain English
This study looked at the experiences of patients with MELAS, a rare genetic condition, by interviewing both patients and doctors. It found that common issues for patients include extreme tiredness (reported by 94% of participants), hearing loss (81%), and problems with memory (69%), all of which significantly affect their quality of life. Understanding these symptoms is crucial for improving care and ensuring clinical studies focus on what matters most to patients. Who this helps: This research benefits patients with MELAS and their healthcare providers by highlighting important symptoms to address in treatment.

Plain English
This research focused on improving methods for combining single-cell RNA sequencing data, which is used to study individual cells in various systems (like different species or tissues). The new method they developed, called sysVI, showed better integration of these datasets and preserved important biological information, making it easier to interpret cell states. The study demonstrated that sysVI outperforms previous methods, leading to clearer results in cell analysis. Who this helps: This helps researchers studying cellular differences in various diseases and treatments.

Plain English
This study compared a new type of blood vessel called Symvess, made from engineered tissue, with traditional veins taken from patients' own bodies to treat severe injuries to limbs caused by accidents. Researchers found that the short-term success rate (primary patency) for Symvess was 86.6%, while it was 91.8% for the traditional veins. Overall, the results showed that Symvess works similarly to autologous veins, making it a good option for patients who cannot use their own veins. Who this helps: This benefits patients with severe limb injuries who lack suitable veins for repair.

Plain English
This study looked at a genetic condition related to the PDHA1 gene, which affects how the body processes energy. Researchers analyzed data from 891 individuals, noting that 53% were female and that the average age of assessment was six years. They found that neonatal or infantile symptoms were most common in 77% of cases, with males generally having shorter survival times of about 7.6 years compared to 12.1 years for females, despite females showing more severe symptoms. Who this helps: This information aids doctors and families by improving understanding and counseling for affected individuals.

Plain English
This study examined the safety and effectiveness of a common type of nail used to treat thigh bone fractures in teenagers. Researchers looked at 105 fractures in 103 children, finding that the nails worked well without causing severe complications like bone death. They determined that using these nails is a safe option for stabilizing fractures in adolescents. Who this helps: This benefits doctors and adolescent patients with femoral shaft fractures.

Plain English
This study focused on how electrons interact with difluoromethane (CH2F2), a gas often used in refrigerants, across a wide range of energy levels from 0.1 to 5000 eV. The researchers found specific measures of how the gas behaves when hit by electrons, which are important for understanding its chemical properties. This research is significant because it helps improve our knowledge of how difluoromethane can impact the environment and human health. Who this helps: This benefits scientists and environmental regulators working on climate safety and health effects related to refrigerants.

Plain English
This study looked at a procedure called phrenic nerve block (PhNB) to treat people suffering from severe hiccups that last longer than 30 days. Out of seven patients treated, the procedure only provided limited or no improvement for most, despite hiccups lasting anywhere from four months to 13 years. This matters because hiccups can significantly impact quality of life, and the study shows that more effective treatment methods are still needed. Who this helps: Patients with long-lasting, severe hiccups.

Plain English
This study looked at how the stretching of the aorta—a major artery in the body—during the heartbeat affects the speed at which blood pressure waves travel. Researchers found that as the aorta stretched more, the speed of these pressure waves also increased, which can alter measurements used in clinical settings. It's important to understand this relationship because it helps ensure that doctors get accurate readings when monitoring heart health. Who this helps: This helps doctors and healthcare providers accurately assess cardiovascular health in patients.

Plain English
This study examines the use of preventive brain radiation in patients with small cell lung cancer (SCLC) to stop the cancer from spreading to the brain. It found that while preventive brain radiation can improve survival rates in patients with limited-stage SCLC, it may not offer additional benefits in extensive-stage cases where MRI monitoring is used. The main downside of this treatment is the potential for cognitive problems, particularly in older patients, but newer techniques and medications may help reduce these side effects. Who this helps: Patients with small cell lung cancer and their doctors.

Plain English
Researchers studied a new medical device called the Esprit BTK, designed to help patients with chronic limb-threatening ischemia (CLTI), a serious condition that can lead to amputations. This device was found to work better than the standard treatment, angioplasty, showing better results in keeping arteries open, while still being safe to use. Specifically, the trial showed that Esprit BTK had improved effectiveness and did not increase safety risks when compared to angioplasty. Who this helps: This research benefits patients suffering from CLTI, particularly those at risk of severe complications like amputation.